Reslizumab subcutaneous (SC) vs placebo
Rate of exacerbations requiring emergency department treatment or admission · people with asthma
Reslizumab subcutaneous (SC) showed no clear difference in rate of exacerbations requiring emergency department treatment or… compared with placebo (high certainty).
1 finding from 1 review
- Rate ratio 0.94 [0.43, 2.05]1 study · 464 participantsHigh